ArticleBMC women's health2020

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study.

Masaki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.